Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection occurring mainly in immunocompromised patients. We recently identified IPA as an emerging co-infection with high mortality in critically ill, but otherwise immunocompetent influenza patients. The neuraminidase inhibitor os...
Main Authors: | Laura Seldeslachts, Lore Vanderbeke, Astrid Fremau, Agustin Reséndiz-Sharpe, Cato Jacobs, Bo Laeveren, Tessa Ostyn, Lieve Naesens, Matthias Brock, Frank L. Van De Veerdonk, Stephanie Humblet-Baron, Erik Verbeken, Katrien Lagrou, Joost Wauters, Greetje Vande Velde |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-12-01
|
Series: | Virulence |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21505594.2021.1974327 |
Similar Items
-
Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis
by: Laura Seldeslachts, et al.
Published: (2021-12-01) -
Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
by: Parvaiz A Koul, et al.
Published: (2024-01-01) -
Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons
by: Seoung Geun Kim, et al.
Published: (2013-04-01) -
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
by: Aeron C. Hurt, et al.
Published: (2016-06-01)